3.0
13 Aug 2012
Former employee, more than 8 years
Lafayette, NJ
Recommend
CEO approval
Business outlook
Pros
Intelligent people. Positive mindset and interaction between disparate groups and departments. Solid leadership. Driven more by the desire to enhance our developmental drugs than by profit margins.
Cons
The only real con was being bought out by a pharma that did not work in the same manner and most certainly did not understand our business culture.